Ensign Peak Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,467,880
Closed -$3.77M 1745
2024
Q1
$3.77M Buy
1,467,880
+670,000
+84% +$1.64M 0.01% 709
2023
Q4
$1.63M Hold
797,880
﹤0.01% 1025
2023
Q3
$1.37M Hold
797,880
﹤0.01% 983
2023
Q2
$1.56M Buy
797,880
+677,353
+562% +$1.59M ﹤0.01% 970
2023
Q1
$335K Hold
120,527
﹤0.01% 1707
2022
Q4
$416K Hold
120,527
﹤0.01% 1659
2022
Q3
$310K Hold
120,527
﹤0.01% 1698
2022
Q2
$292K Sell
120,527
-20,000
-14% -$52.5K ﹤0.01% 1690
2022
Q1
$579K Hold
140,527
﹤0.01% 1485
2021
Q4
$1.81M Buy
140,527
+40,027
+40% +$443K ﹤0.01% 1003
2021
Q3
$1.08M Sell
100,500
-234,136
-70% -$2.13M ﹤0.01% 1402
2021
Q2
$3.06M Hold
334,636
0.01% 876
2021
Q1
$3.16M Sell
334,636
-3,255
-1% -$44.8K 0.01% 837
2020
Q4
$1.33M Buy
337,891
+28,038
+9% +$84.8K ﹤0.01% 1273
2020
Q3
$822K Sell
309,853
-363,064
-54% -$1.35M ﹤0.01% 1391
2020
Q2
$4.47M Buy
672,917
+323,401
+93% +$2.18M 0.01% 642
2020
Q1
$2.04M Sell
349,516
-24,860
-7% -$209K 0.01% 819
2019
Q4
$3.36M Buy
+374,376
New +$3.12M 0.01% 791

Other funds holding GRTS

Ensign Peak Advisors's GRTS Position: Q2 2024 in Review

Ensign Peak Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 1,467,880 shares — an estimated $3.77M sold.

Ensign Peak Advisors first reported a position in GRTS in Q4 2019 and held it in 18 quarters. The position peaked at $4.47M in Q2 2020. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

  • Ensign Peak Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Ensign Peak Advisors sold 1,467,880 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $3.77M.
  • Ensign Peak Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q4 2019 and held it in 18 quarters.
  • Ensign Peak Advisors's Gritstone bio, Inc. Common Stock position peaked at $4.47M in Q2 2020.
  • 79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on Ensign Peak Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.